A detailed history of Russell Investments Group, Ltd. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 68 shares of OCUL stock, worth $613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68
Holding current value
$613
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.45 - $9.23 $438 - $627
68 New
68 $0
Q4 2022

Feb 08, 2023

SELL
$2.61 - $4.41 $45,367 - $76,654
-17,382 Reduced 56.17%
13,561 $38,000
Q3 2022

Nov 04, 2022

BUY
$4.09 - $6.5 $126,556 - $201,129
30,943 New
30,943 $128,000
Q1 2021

May 10, 2021

SELL
$15.82 - $22.11 $8,890 - $12,425
-562 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$7.91 - $22.95 $4,445 - $12,897
562 New
562 $11,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $694M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.